Inhalation Research Services chosen for new research project worth 1.45 million SEK by US pharma company Kumar Jeetendra | July 18, 2022 (Stockholm 18 July 2022) A US company with an extensive pipeline in medical dermatology has chosen Inhalation Research Services (IRS), ISAB’s contract research organization, for a research project worth 1.45 million SEK (1.36 K Euro) into a new repurposed drug that is being reformulated for administration via the lungs. ISAB’s world-class expertise in inhalation, and …
Cipla Health signs agreement to acquire Endura Mass Kumar Jeetendra | July 14, 2022 Mumbai, India; July 14, 2022: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Company” or “Cipla”) announced today that Cipla Health Limited (CHL), wholly owned subsidiary and consumer healthcare arm of the Company has signed definitive agreements for acquisition of Endura Mass, a renowned nutritional supplement brand in the category of …
Dry Compressed Air – An essential prescription for the pharmaceutical industry Kumar Jeetendra | July 14, 2022 Quality compressed air is an essential factor in providing the necessary framework to the pharmaceutical industry. It powers a wide gamut of processing, manufacturing, and packaging operations that requires pneumatic processes. Manufacturing of tablets and capsules for giving the right texture, color, and flavor. Maintaining the right balance of the ingredients, dry compressed air goes …
Vaccizone selects Exothera for process development and GMP manufacturing of its SARS CoV 2 vaccine based on proprietary ASC technology Kumar Jeetendra | July 14, 2022 Istanbul (Turkey) – 6th July 2022 – Life Science Newswire – Vaccizone, a vaccine development company focusing on innovative antigen delivery technology, selected Exothera S.A. to fast-track process development of its SARS CoV 2 vaccine for European clinical trials. Vaccizone has developed and patented a novel method for delivering antigens and bioactive compounds which can …
WuXi STA Opens New Large-scale Oligonucleotide and Peptide Manufacturing Facility Kumar Jeetendra | July 7, 2022 SHANGHAI , July 7, 2022: WuXi STA, a subsidiary of WuXi AppTec, today announced the opening of a new large-scale oligonucleotide and peptide manufacturing facility at its Changzhou campus. The new facility underscores WuXi STA’s ongoing commitment to enhance its capacity and capability to meet the fast-growing customer needs for oligonucleotide and peptide therapeutics development …
Bio-Gate concludes another cooperation agreement with leading multinational implant manufacturer Kumar Jeetendra | July 7, 2022 Nuremberg/Bremen, 5 July 2022 – Bio-Gate AG (ISIN DE000BGAG981), a leading provider in the field of innovative health technologies, has concluded a contract with a leading multinational medical device manufacturer for the coating of orthopaedic implants in human medicine. As part of the cooperation and the joint project management, Bio-Gate is responsible for the application …
Mr. Amit Singh Chadha Wins the Indian Business Inspirational stories recognition for his entrepreneurial aptitude and skills Kumar Jeetendra | June 22, 2022 Mr. Amit Singh Chadha, Co-founder and CEO at Advent Chembio Pvt ltd, a Mumbai based Chemicals Manufacturing Company and a leading supplier of Fine & Specialty chemicals, Customized products and Performance Materials wins the Indian Business Inspirational stories recognition for his entrepreneurial aptitude and skills. The Business Growth Meet was conducted by Business Leadership League …
Ground-breaking regional anesthesia system to become available in Saudi Arabia, the UAE and Bahrain Kumar Jeetendra | April 13, 2022 UK-based Medovate – a dynamic medical device development company – has today announced an agreement with AKSIA Healthcare FZC to distribute its SAFIRA™ (SAFer Injection for Regional Anesthesia) product range in Saudi Arabia, the UAE and Bahrain. SAFIRA™ is a revolutionary Class II medical device system which is transforming regional anesthesia around the world by making it a one-person procedure …
Top 10 Indian origin, BA/BE CROs to look upon in 2022 Kumar Jeetendra | April 2, 2022 The key to making profits in the generic drug market is reaching the market as early as possible by getting proper regulatory approval. Generic medicines play an essential role in the pharmaceutical market because of their lower cost than branded drug molecules. Manufacturers of Generic Pharmaceuticals need not begin from scratch and carry out R&D, …
Hester Biosciences Limited, India’s 2nd Largest Poultry Vaccine Manufacturer, ventures into the Pet Care Industry Kumar Jeetendra | March 23, 2022 22 March 2022: Hester Biosciences Limited is all set to expand into the rapidly growing Pet Care sector this April. India has the fastest-growing pet care market worldwide, with it growing by 14% in 2022, making this an exciting and valuable opportunity for the poultry vaccine giant. Hester’s comprehensive knowledge of animal biology, cutting-edge R&D …
Molecular Health and collaborators prove new analytical approach that leverages real-world data to anticipate molecular causation of adverse drug reactions Kumar Jeetendra | March 10, 2022 Molecular Health and collaborators at the University of Florida College of Pharmacy, Takeda Oncology, and thinkQ² published a triad of articles that describe and prove the concept of a novel systems approach to elucidate molecular mechanisms of drug toxicities using real-world data (RWD). “We have established an approach that transforms real-world, in-human treatment outcomes and …
Arctoris and Evariste Technologies form a Joint Venture to Identify Novel Small Molecule cMET Inhibitors for Non-Small Cell Lung Cancer Kumar Jeetendra | March 7, 2022 07 March 2022, Oxford and London – Life Science Newswire – Arctoris, a tech-enabled biopharma company, and Evariste Technologies, an AI-drug discovery company, today announced they have formed a joint venture to identify novel small molecule kinase inhibitors for treatment of patients with Non-Small Cell Lung Cancer (NSCLC). Current treatment options for NSCLC are limited, …
